Renal effects of gadopentetate dimeglumine in patients with normal and impaired renal function

European Journal of Medical Research

Volumn 10, Issue 4, 2005, Pages 149-154

  Hoffmann, Ute ^a,c   Fischereder, M ^b   Reil, A ^a   Fischer, M ^a   Link, J ^a   Kramer B K ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Creatinine; Gadolinium; Nephropharmacology; Renal function

Indexed keywords

CONTRAST MEDIUM; CREATININE; GADOLINIUM PENTETATE MEGLUMINE; UREA;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC VALUE; DOSE KIDNEY FUNCTION RELATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEIGHT; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; STATISTICAL SIGNIFICANCE; UREA BLOOD LEVEL;

CONTRAST MEDIA; CREATININE; FEMALE; GADOLINIUM DTPA; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 17844378507     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Solomon R (1998) Contrast-medium-induced acute renal failure. Kidney Int 53: 230-242
2. Krämer BK, Kammerl M, Schweda F, Schreiber M (1999) A primer in radiocontrast-induced nephropathy. Nephrol Dial Transplant 14: 2830-2834
3. Bush RL, Lin PH, Bianco CC, Lumsden AB, Gunnoud AB, Terramani TT, Brinkman WT, Martin LG, Weiss VJ (2002) Endovascular aortic aneurysm repair in patients with renal dysfunction or severe contrast allergy: Utility of imaging modalities without iodinated contrast. Ann Vasc Surg 16: 537-44
4. Niendorf HP, Alhassan A, Geens VR, Claub W (1994) Safety review of gadopentetate dimeglumine extended clinical experience after more than five million applications. Invest Radiol 29: 179-182
5. Runge VM (2001) Safety of magnetic resonance contrast media. Top Magn Reson Imaging 12: 309-14
6. Haustein J, Niendorf HP, Krestin G, Louton T, Schuhmann-Giampieri G, Clauss W, Junge W (1992) Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure. Invest Radiol 27: 153-156
7. Prince MR, Arnoldus C, Frisoli JK (1996) Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 6:162-6
8. Arsenault TM, King BF, Marsh JW Jr, Goodman JA, Weaver AL, Wood CP, Ehman RL (1996) Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of an initial experience. Mayo Clin Proc 71: 1150-4
9. Schuhmann-Giampieri G, Krestin G (1991) Pharmacokinetics of GD-DTPA in patients with chronic renal failure. Invest Radiol 26: 975-9
10. Dorsam J, Knopp MV, Schad L, Piesche S, Carl S, Oesingmann N (1995) Elimination of gadolinium-DTPA by peritoneal dialyses. Nephrol Dial Transplant 10: 1228-1230
11. Choyke PL, Girton ME, Vaughan EM, Frank JA, Austin HA (1995) Clearance of gadolinium chelates by hemodialyses: an in vitro study. J Magn Reson Imaging 5: 470-472
12. Nyman U, Elmstahl B, Leander P, Nilsson M, Golman K, Almen T (2002) Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 223: 311-318
13. Erley CM, Bader BB, Berger ED, Tuncel N, Winkler S, Tepe G, Risler T, Duda S (2004) Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients. Nephrol Dial Transplant 19: 2526-2531
14. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41
15. Carr JJ (1994) Magnetic resonance contrast agents for neuroimaging. Safety issues. Neuroimaging Clin N Am 4: 43-54
16. Hammer FD, Gofette PP, Malaise J, Mathurin P (1999) Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography. Eur Radiol 9: 128-136
17. Nelson KL, Gifford LM, Lauber-Huber C, Gross CA, Lasser TA (1995) Clinical safety of gadopentetate dimeglumine. Radiology 196: 439-43
18. Murphy KJ, Brunberg JA, Cohan RH (1996) Adverse reactions to gadolinium contrast media: a review of 36 cases. Am J Roentgenol 167: 847-9
19. Cochran ST, Bmyea K, Sayre JW (2001) Trends in adverse events after IV administration of contrast media. Am J Roentgenol 176: 1385-8
20. Spinosa DJ, Matsumoto AH, Angle JF, Hagspiel KD, Leung DA, Hartwell GD (2001) Gadolinium contrast agents: their role in vascular and nonvascular diagnostic angiography and interventions. Tech Vasc Interv Radiol 4: 45-52
21. Barrett B, Carlisle E (1993) Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188: 171-178
22. Hoffmann U, Fischereder M, Krüger B, Drobnik W, Krämer BK (2004) The value of N-acetylcysteine in the prevention of radiocontrast-induced nephropathy appears questionable. J Am Soc Nephrol 15:407-10
23. Hoffmann U, Banas B, Fischereder M, Krämer BK (2004) N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: clinical trials and end points. Kidney Blood Press Res 27:161-6
24. Wagner HJ, Kalinowski M, Klose KJ, Alfke AH (2001) The use of gadolinium chelates for X-ray digital subtraction angiography. Invest Radiol 36: 257-65
25. Tervahartiala P, Kivisaari L, Kivisaari R, Cirtanen I, Standertskjold-Nordenstam CG (1991) Contrast media-induced renal tubular vacuolization. A light and electron microscopic study on rat kidneys. Invest Radiol 26: 882-7
26. Murphy KP, Szopinsky KT, Cohan RH, Mermillod B, Ellis JH (1999) Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk; a survey of the American Society of Neuroradiology Fellowship Directors. Acad Radiol 6: 656-64
27. Katzberg RW, Sahler LG, Duda SW (1990) Renal handling and physiologic effects of the paramagnetic contrast medium Gd-DOTA. Invest Radiol 25: 714-719
28. Brillet G, Dubois M, Beaufils H, Bourbouze R, Eray G (1994) Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats. Invest Radiol 29: 352-354
29. Gemery I, Idelson B, Reid S, Yucel EK, Pagan-Marin H, Ali S, Casserly L (1998) Acute renal failure after arteriography with a gadolinium-based contrast agent. Am J Roentgenol 171: 1277-8
30. Rieger J, Sitter T, Toepfer M, Linsenmaier U, Pfeifer KJ, Schiffl H (2002) Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant 17: 824-28